Treatment

Chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) are complex conditions involving a range of abdominal and bowel symptoms, including bloating, straining, abdominal pain, and...

Symptom Relief for Refractory IBS-C

Over the past decade, new therapies for IBS-C have emerged, but treatment options remain limited for patients unresponsive to secretagogues....
Kathleen Ferrell,
CURATED BY:
Kathleen Ferrell,
DMSc, MPAS, PA-C

Real-Time Symptom Tracking Tool Shows Promise for Personalized IBS Care

This large, multicenter psychometric validation study assessed the reliability and validity of an experience sampling method-based patient-reported outcome measure (ESM-PROM)...
Carol M. Antequera,
CURATED BY:
Carol M. Antequera,
DMSc, PA-C

Herbal Remedies Show Promise for IBS-C Relief

Accurate diagnosis of constipation-predominant irritable bowel syndrome (IBS-C) can be challenging due to symptom subjectivity and overlapping etiologies such as...
Kathleen Ferrell,
CURATED BY:
Kathleen Ferrell,
DMSc, MPAS, PA-C

Linaclotide Significantly Improves Abdominal Symptoms in Patients With IBS-C

This randomized controlled trial investigated the effectiveness of linaclotide compared to placebo in reducing abdominal symptoms (bloating, discomfort, pain) in...
Amy Stewart,
CURATED BY:
Amy Stewart,
MSN, FNP-C

Antidepressants and Psychological Therapies Effective in Treating IBS

This updated systematic review and meta-analysis aimed to assess the effectiveness of antidepressants and psychological therapies in treating irritable bowel...
Amy Stewart,
CURATED BY:
Amy Stewart,
MSN, FNP-C
LONDON, UK – NOVEMBER 30, 2022: Used, empty blister packs of various generic brands of 10mg Amitriptyline Hydrochloride

Amitriptyline Shows Significant Improvement in IBS Symptoms in Primary Care Setting

A multicenter, double-blind, placebo-controlled trial was conducted to determine if amitriptyline (10-30 mg nightly) is superior to placebo for improving...
Amy Stewart,
CURATED BY:
Amy Stewart,
MSN, FNP-C
Share